Interview with Philippe van der Hofstadt, Founder & CEO, B & C Group
Can you tell our readers about B&C Groups main mission and also highlight some of its most notable achievements and milestones since its founding in 1999? Earlier in my career,…
Address: Watson & Crick Hill, Rue Granbonpré 11, B-1348 Mont-Saint-Guibert,Belgium
Tel: +32 (0)10 237 444
Web: http://www.bnc-group.com/
B & C Group is a Packaging & Logistics Company solely dedicated to (Pre)Clinical Research.
Established in 1999 as a niche provider of ground transport for batched frozen specimen shipments, B & C was the first company of its kind to offer full specimen tracking and on-site data cleaning. Today we offer a unique combination of logistics services through our network.
B & C Group adds value to your clinical research logistics process by its unique approach on centralization and integration combined with experience, expertise and geographic reach.
Since January 2009, B & C Group has relocated its two sites in Mechelen and Wavre to the former Eli Lilly IMP Packaging & distribution facility in Mont-St-Guibert (South of Brussels – Belgium).
B & C provides integrated Packaging and Logistics services for the Clinical Trials sponsored or supported by:
Pharmaceutical Companies
Biotechnology Companies
Central Laboratories
Contract Research Organizations
Academic Institutions
Investigational Sites
Can you tell our readers about B&C Groups main mission and also highlight some of its most notable achievements and milestones since its founding in 1999? Earlier in my career,…
UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including Computer-Aided Drug Design (CADD) and AI, while striving to maintain a patient-centric focus.…
Pfizer’s David Isom and Monica Mihedji, writing in the November 2023 edition of the DIA’s Global Forum magazine, examine how the European Medicines Agency is attempting to integrate the use…
Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish and project considerable influence when it comes to its abilities…
The European Coalition for Access to Comprehensive Genomic Profiling (ECGP) is a new initiative made up of industry association the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), molecular diagnostics firms Exact…
Janssen has the lofty aim of reaching USD 60bn dollars in sales by 2025, an 8bn increase on the 2021 figure, despite some high-profile losses of exclusivity and the spin-off…
There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an independent company spun off from…
Representatives of Belgian associations for innovative pharma, generics and biosimilars, medtech, OTC, biotech, hospitals, and medical professionals share their key agenda priorities. These include where they feel that change is…
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Perhaps to the surprise of many, Belgium is the world’s second-largest producer of vaccines, behind only the US, and – capitalising on its years of experience in the field –…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously struggling biotech he…
Belgian healthcare performs strongly across most metrics and international comparisons, but – as elsewhere – there remains room for improvement in terms of integrating patient feedback and experience into the…
20-year Astellas veteran Mark Dekker – now back in his home country of the Netherlands and overseeing the Benelux cluster having primarily developed his career in emerging European markets –…
See our Cookie Privacy Policy Here